RSV Season Is Coming: Why the First Year Matters Most — and How to Protect Your Baby

What Is RSV?

Respiratory syncytial virus is one of the most common respiratory viruses in the world. Almost every child is infected at some point, and most recover with nothing more than cold-like symptoms.

The reason doctors pay so much attention to it is not how often it infects children, but how severe it can be in a small group of them. RSV is the leading viral cause of lower respiratory infection in children under five worldwide, and the most common cause of pneumonia and bronchiolitis in infants.

In older children and adults, RSV usually behaves like a common cold. In a baby whose airways are only a few millimetres wide and whose immune system is still learning, the same virus can cause widespread inflammation and narrowing of the small airways.

Why Babies Under One Are at Higher Risk

Two things make early infancy different.

The first is anatomy. An infant's bronchioles — the smallest branches of the airway — are tiny. A small amount of swelling and mucus that would barely affect an adult can significantly obstruct an infant's breathing.

The second is immunity. Babies are born with antibodies passed from their mother, but levels fall over the first months of life, and their own immune system is still developing. Premature babies, babies with congenital heart or lung disease, and babies with weakened immunity are at particularly high risk.

Severe RSV infection in the first year has also been linked to reduced lung function that can persist for years, which is one reason prevention in infancy matters beyond the immediate illness.

What an RSV Infection Looks Like

After exposure, symptoms usually appear within four to six days.

Most children start with upper respiratory symptoms — a blocked or runny nose, cough, and often a fever. The fever is commonly low to moderate, though it can occasionally be high. Many children improve from this point without further problems.

In some babies, however, the infection moves down into the lower airways and becomes bronchiolitis or pneumonia. The signs to watch for are different from an ordinary cold:

• fast or laboured breathing, or visible pulling in of the ribs between or below the ribs;
• wheezing, grunting, or a pause in breathing (apnoea), especially in very young infants;
• poor feeding, fewer wet nappies, or difficulty finishing feeds;
• unusual sleepiness, irritability, or a bluish tinge around the lips.

These are reasons to seek medical assessment promptly, not to wait at home.

There Is No Antiviral — So Prevention Is the Strategy

For most viral illnesses, families ask what medicine will cure it. With RSV, the honest answer is that there is currently no effective antiviral drug for routine treatment. Care focuses on supporting breathing and feeding while the immune system clears the virus.

That makes prevention the more important half of the conversation. Hand hygiene, keeping sick contacts away from newborns, avoiding crowded indoor spaces during the season, and not smoking around a baby all reduce exposure. They lower the chance of infection, but they cannot eliminate it.

Specific prevention is now possible as well. A long-acting monoclonal antibody against RSV has been developed for infants. Unlike a vaccine, which teaches the immune system to respond, a monoclonal antibody provides ready-made antibodies directly — protection is available immediately rather than after a delay.

The Long-Acting Monoclonal Antibody Option

In January 2026, the first RSV preventive monoclonal antibody specifically for infants aged 0 to 1 year was approved in China by the National Medical Products Administration. It is given as a single dose and is designed to protect a baby through the RSV season.

For parents, the practical points are:

• It is prevention, not treatment. It is given before or during the RSV season, not to a child who is already infected.
• One dose covers the season. The antibody is long-acting, so a single injection is intended to last through the months when RSV circulates.
• Eligibility depends on age and risk. Guidance differs between countries and changes over time. Babies born prematurely, or with heart, lung or immune conditions, are usually prioritised.
• It does not replace the usual checks. Routine vaccinations and well-baby visits should continue as normal.

Whether a particular baby should receive it, and when, is a decision to make with a pediatrician who knows the child's history and the local RSV season.

What Parents Can Do This Season

Practical steps, in order of how much difference they make:

• Keep newborn babies away from anyone with a cough or cold, including relatives and visitors.
• Wash hands before holding a baby, and ask visitors to do the same.
• Avoid crowded, enclosed spaces during the peak months, particularly with infants under six months.
• Keep the home smoke-free — smoke exposure increases the risk of severe RSV.
• Breastfeed where possible; it provides antibodies and other protective factors.
• Learn the warning signs above, and act early if breathing changes.
• Ask your pediatrician whether monoclonal antibody protection is appropriate for your child.

Where to Get Advice

Jingdu's vaccination clinic advises families on RSV prevention and on the routine immunisation schedule for infants and young children. International families can request a remote review of the baby's age, birth history and vaccination record before travelling, so that any preventive treatment can be planned around arrival dates.

This article is general health information. It does not replace an individual assessment, and treatment decisions should always be made with a qualified pediatrician.

Related Reading

• Growing Pains or a Sports Injury? Jingdu Opens a Pediatric Sports Injury Clinic
• Inside Jingdu's Hematology & Transplant Center

← Back to News